South Africa BCG booster trials seek low-cost weapon against COVID-19

Malaysia News News

South Africa BCG booster trials seek low-cost weapon against COVID-19
Malaysia Latest News,Malaysia Headlines
  • 📰 Reuters
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

South African biotech group TASK has started testing the century-old BCG vaccine, widely used against tuberculosis, to protect against COVID-19. More here:

South African biotech group TASK this month started the continent’s first trial to see whether 250 high-risk workers given a booster dose of BCG vaccine show better protection against COVID-19 than the same number given a placebo.

But unlike those countries, where BCG vaccinations at birth aren’t the norm, South Africa’s trial involves injecting people for a second time. BCG injections are mandatory at birth in South Africa, where TB is a leading killer. Trying out a new medical intervention in Africa always rings alarm bells because of an unfortunate history of big pharmaceutical companies using Africans as guinea pigs.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Reuters /  🏆 2. in US

Malaysia Latest News, Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

As China faces a backlash in the West, Xi needs Africa more than everAs China faces a backlash in the West, Xi needs Africa more than everChinese leader Xi Jinping made preserving diplomatic ties in Africa a centerpiece of his opening address at the World Health Assembly earlier this week, as Beijing faces a backlash among some Western democracies for its role in the coronavirus pandemic
Read more »

Dollar shunned as vaccine hopes lift risk appetiteDollar shunned as vaccine hopes lift risk appetiteThe dollar nursed losses against major currencies on Tuesday after encouraging results from the trial of a vaccine for COVID-19 improved sentiment in a boost to riskier assets.
Read more »

FDA appears to soften stance on hydroxychloroquine after Trump says he takes malaria drugFDA appears to soften stance on hydroxychloroquine after Trump says he takes malaria drugThe FDA advised consumers against taking hydroxychloroquine for Covid-19 outside a hospital or formal clinical trial setting due to the risk of 'serious heart rhythm problems.'
Read more »

What COVID-19 Is Doing to Our Mental HealthWhat COVID-19 Is Doing to Our Mental HealthAmericans are reporting significant and sustained increases in symptoms of depression and anxiety related to the COVID-19 pandemic, according to recent data from Healthline and YouGov’s COVID-19 tracker.
Read more »

People Mount Strong Immune Responses to COVID-19People Mount Strong Immune Responses to COVID-19Good news in the search for a coronavirus vaccine: People with COVID-19 have robust immune responses against the virus, which could increase the likelihood of a successful vaccine, scientists say.
Read more »

Today's Headlines: California's progress against COVID-19Today's Headlines: California's progress against COVID-19Though COVID-19 deaths continue to rise and there are concerns about the future, some encouraging signs are emerging in California's fight against the coronavirus.
Read more »



Render Time: 2025-04-03 01:39:32